{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:09Z","timestamp":1792791489119,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Neonatal hyperglycemia significantly increases risk for retinopathy of prematurity (ROP) in preterm infants, independent of other major ROP risk factors. However, glucose thresholds predictive of ROP remain undefined. This prospective study explored two glycemic metrics\u2014mean blood glucose and glycated hemoglobin [specifically, glycated fetal hemoglobin for non-transfused infants and a neonatal-adapted hemoglobin A1C assay for transfused infants]\u2014to identify thresholds associated with severe ROP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Infants born at gestational ages &amp;lt;30 weeks and hospitalized at DeVos Children's Hospital (September 2022\u2013August 2024) were eligible. The final cohort included 98 infants. Blood glucose was monitored per clinical care, and glycated hemoglobin was measured on Day 30 using a research prototype assay. Eye exams were conducted per ROP protocol. Predictive thresholds for each biomarker were evaluated using AUC\u2013ROC analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Most cases of severe ROP occurred in the transfused participants, who represent the earliest gestational ages and sickest infants. Both glycated hemoglobin (A1C) and 30-day mean blood glucose were significantly higher in infants with severe ROP compared to counterparts with mild or no ROP. Both biomarkers demonstrated concordant positive predictive values of 94%. Predictive cutoffs were identified as 5.66% for A1C (<jats:italic>p<\/jats:italic>\u2009=\u20090.003) and 93.8\u2005mg\/dl for 30-day mean glucose (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Severe ROP may represent a clinical outcome for defining neonatal glycemic thresholds. In this pilot study, preliminary cutoffs for two independent glycemic biomarkers are lower than current NICU intervention criteria; further investigation is needed to potentially refine glucose strategies for ROP mitigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1688879","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:41Z","timestamp":1760502221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying neonatal hyperglycemia thresholds in preterm infants based on retinopathy of prematurity outcomes: proof-of-concept study"],"prefix":"10.3389","volume":"13","author":[{"given":"Tammy","family":"Movsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nadernejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Dudick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Pribyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Geddie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000104174","article-title":"Glucose regulation in preterm newborn infants","volume":"68","author":"Mitanchez","year":"2007","journal-title":"Horm Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"F126","DOI":"10.1136\/adc.2008.154716","article-title":"Management of hyperglycaemia in the preterm infant","volume":"95","author":"Ogilvy-Stuart","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41390-023-02628-9","article-title":"Hyperglycemia and prematurity: a narrative review","volume":"94","author":"Angelis","year":"2023","journal-title":"Pediatr Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jpeds.2010.04.032","article-title":"Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study","volume":"157","author":"Beardsall","year":"2010","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/etm.2022.11643","article-title":"Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (review)","volume":"24","author":"Chen","year":"2022","journal-title":"Exp Ther Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM197608192950804","article-title":"Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus","volume":"295","author":"Koenig","year":"1976","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1056\/NEJMc1301021","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"368","author":"Hartnett","year":"2013","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.retram.2019.01.005","article-title":"Update of inflammatory proliferative retinopathy: ischemia, hypoxia and angiogenesis","volume":"67","author":"Aouiss","year":"2019","journal-title":"Curr Res Transl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/dmcn.15468","article-title":"Retinopathy of prematurity","volume":"65","author":"Dammann","year":"2023","journal-title":"Dev Med Child Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/pch\/21.2.101","article-title":"Retinopathy of prematurity: an update on screening and management","volume":"21","author":"Jefferies","year":"2016","journal-title":"Paediatr Child Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.jp.7210879","article-title":"Hyperglycemia and retinopathy of prematurity in very low birth weight infants","volume":"23","author":"Garg","year":"2003","journal-title":"J Perinatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1003477","DOI":"10.1371\/journal.pmed.1003477","article-title":"Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: a cohort study","volume":"17","author":"Kermorvant-Duchemin","year":"2020","journal-title":"PLoS Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/archdischild-2020-321449","article-title":"Outcomes of very preterm infants with neonatal hyperglycaemia: a systematic review and meta-analysis","volume":"107","author":"Rath","year":"2022","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22321","DOI":"10.1038\/s41598-021-01861-8","article-title":"Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity","volume":"11","author":"Almeida","year":"2021","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e140363","DOI":"10.1172\/jci.insight.140363","article-title":"IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants","volume":"5","author":"Cakir","year":"2020","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2431-13-78","article-title":"Hyperglycemia as a risk factor for the development of retinopathy of prematurity","volume":"13","author":"Mohamed","year":"2013","journal-title":"BMC Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000088199","article-title":"Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants","volume":"89","author":"Ertl","year":"2006","journal-title":"Neonatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/jp.2010.152","article-title":"Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity","volume":"31","author":"Kaempf","year":"2011","journal-title":"J Perinatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jp.2014.49","article-title":"A prospective study on hyperglycemia and retinopathy of prematurity","volume":"34","author":"Mohsen","year":"2014","journal-title":"J Perinatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2796.2012.02514.x","article-title":"The unexpected pathway to the creation of the HbA1c test and the discovery of AGE's","volume":"271","author":"Cerami","year":"2012","journal-title":"J Intern Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/193229680900300306","article-title":"A review of the challenge in measuring hemoglobin A1c","volume":"3","author":"Weykamp","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/IAE.0000000000002949","article-title":"Glycemic variability is associated with treatment requiring retinopathy of prematurity: a case-control study","volume":"41","author":"Jagla","year":"2021","journal-title":"Retina"},{"key":"B25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-0035-1565999","article-title":"Insulin, hyperglycemia, and severe retinopathy of prematurity in extremely low-birth-weight infants","volume":"33","author":"Lee","year":"2016","journal-title":"Am J Perinatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.phrs.2015.11.027","article-title":"Targeting VEGF in eye neovascularization: what\u2019s new?: a comprehensive review on current therapies and oligonucleotide-based interventions under development","volume":"103","author":"Amadio","year":"2016","journal-title":"Pharmacol Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF In signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retinal Eye Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.34763\/devperiodmed.20192301.0714","article-title":"Impact of early glycemic variability on mortality and neurologic outcome of very low birth weight infants: data from a continuous glucose monitoring system","volume":"23","author":"Jagla","year":"2019","journal-title":"Dev Period Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2417431","DOI":"10.1001\/jamanetworkopen.2024.17431","article-title":"Clinical practice guideline for red blood cell transfusion thresholds in very preterm neonates","volume":"7","author":"Deschmann","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12886-022-02591-9","article-title":"Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants","volume":"22","author":"Yucel","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2021053924","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of prematurity: a global perspective and recent developments","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.4103\/IJO.IJO_692_23","article-title":"Fetal hemoglobin, blood transfusion, and retinopathy of prematurity in preterm infants: an observational, prospective study","volume":"71","author":"Prasad","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41390-019-0580-8","article-title":"The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity","volume":"87","author":"Movsas","year":"2019","journal-title":"Pediatr Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"30106","DOI":"10.1016\/j.jaapos.2020.02.011","article-title":"The association between high levels of luteinizing hormone and proliferative retinopathy of prematurity in female preterm infants","volume":"20","author":"Movsas","year":"2020","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"B36","doi-asserted-by":"publisher","first-page":"s209","DOI":"10.2450\/2013.0271-12","article-title":"Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus","volume":"12","author":"Sugimoto","year":"2014","journal-title":"Blood Transfus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/dmrr.415","article-title":"Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives","volume":"19","author":"Caldwell","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/jcm14041343","article-title":"Retinal biomarkers in diabetic retinopathy: from early detection to personalized treatment","volume":"14","author":"Chondrozoumakis","year":"2025","journal-title":"J Clin Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1688879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:44Z","timestamp":1760502224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1688879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":38,"alternative-id":["10.3389\/fped.2025.1688879"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1688879","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1688879"}}